Immuno-Genetic “Two-Hit” Therapy: Engineered MSC Exosomes that Reprogram Host Immunity and Deliver Parasite-Targeted siRNA

Sadr et al. (2024) review how MSCs can dampen inflammation and synergize with antiparasitic drugs, hinting at an underused lever: host immunomodulation to tackle resistance. Rather than administering whole MSCs (which bring heterogeneity and safety concerns), this project zeroes in on exosomes—engineerable, scalable vesicles—to deliver a two-hit payload. First, load exosomes with miRNA/proteins that skew macrophages toward an M1-like, parasite-clearing phenotype (tempering the “too much” or “too little” inflammation problem highlighted in MSC reviews). Second, incorporate siRNA or antisense oligos that knock down Plasmodium genes implicated in artemisinin resistance (e.g., kelch13), echoing the target focus seen in Cheuka et al. (2024) and Pradhan et al. (2022, who docked withaferin A to PfK13). To target infected erythrocytes, display ligands or scFvs recognizing iRBC surface antigens (PfEMP1 variants) on exosomes. Compared to Sadr et al.’s MSC-focused approach, this is a precise, modular, and potentially safer platform that directly engages both the host and parasite. If successful, it could convert failing combinations into effective ones by blunting host-driven pathology and reversing parasite resistance at the transcript level.

References:

1. Anti-inflammatory and immunomodulatory effects of mesenchymal stem cell therapy on parasitic drug resistance. Soheil Sadr, Pouria Ahmadi Simab, Mahta Niazi, Z. Yousefsani, Narges Lotfalizadeh, Ashkan Hajjafari, H. Borji (2024). Expert Review of Anti-Infective Therapy.
2. Isolation and structure elucidation of a steroidal moiety from Withania somnifera and in silico evaluation of antimalarial efficacy against artemisinin resistance Plasmodium falciparum kelch 13 protein. D. Pradhan, P. Biswasroy, D. Sahu, G. Ghosh, Goutam Rath (2022). Journal of Biomolecular Structure and Dynamics.
3. Emerging Drug Targets for Antimalarial Drug Discovery: Validation and Insights into Molecular Mechanisms of Function.. P. Cheuka, Paul Njaria, G. Mayoka, Evelyn Funjika (2024). Journal of Medicinal Chemistry.